What is Afgritech?
Afgritech, through its specialization in premium rumen bypass protein products, leverages proprietary ExpandaTherm technology to enhance protein values derived from canola and soy. The company's offerings encompass product development, value-added technologies, private label manufacturing, and licensing agreements, targeting innovation within the dairy industry. Their business model is designed to provide competitive pricing and customized manufacturing solutions for both producers and feed suppliers.
How much funding has Afgritech raised?
Afgritech has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Afgritech?
The substantial late-stage funding indicates Afgritech is poised for significant scaling and market expansion. This capital injection is likely to fuel further research and development into their ExpandaTherm technology, potentially broadening their product portfolio and enhancing their market penetration in the animal nutrition sector. Strategic partnerships and potential acquisitions may also be on the horizon as the company solidifies its growth strategy.
See full Afgritech company page
